Let’s consider the extent to which women execs are preventing other women from breaking the glass ceiling.
All eyes are on Oklahoma as the first state-level case seeking to assign liability for the opioid crisis. Here’s why pharma marketers should brace for change in its wake.
Sander Flaum is principal of Flaum Navigators.
Yesterday’s Insys verdict sends a strong message: Marketing abuses once excused with a mere monetary fine could now result in jail time, and it’s not only drug makers taking heat.
Even when pharma produces breakthroughs, critics still find something or other to nitpick.
Another year, another group of seriously smart and impressive Transformers.
Please login or register first to view this content.